March 25, 2021 05:24 AM EDTUpdated March 30, 05:15 AM

Neuro upstart launches out of RA Capital’s low-profile incubator with Big Pharma vets, clinical drugs and $80M

As a pain researcher of 20-plus years, Valerie Morisset doesn’t get excited about new drug ideas easily.

So when Andrew Levin from RA Capital called …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Neu­ro up­start launch­es out of RA Cap­i­tal’s low-pro­file in­cu­ba­tor with Big Phar­ma vets, clin­i­cal drugs and $80M